MERIDIANDECISION INTELLIGENCEOwner deskOwnerPublic screen
My judgments
MERIDIAN / EXPLORE

From a question,
to the next decision.

View

Skin

YOUR DECISION WORKSPACEOwner onlyStart a new question Open my judgments →Owner operations desk →
Owner sign-in →Signed in as the ownerSign out — see what a visitor sees →End the Cloudflare Access session too →
Reading language
The screen, the questions and the judgments read in English where an English reading has been made. The Korean originals are unchanged, and evidence stays in the language it was written in.

Can We Waive the Rights to a Pandemic Treatment and Still Guarantee Supply?

2035The near futureDeadline · 7 days until production reservations are confirmed

An extension of it

All people, institutions, events, figures, and future technologies in every issue are a synthetic premise. Background documents are sources for topic discovery and are not evidence of future facts or probabilities.

The question to decide

The secured treatment covers only 30% of the requested volume. The incumbent manufacturer demands exclusive purchasing in exchange for capacity expansion, and quality verification of the new producers is not finished. Before the window for reserving volume closes, how should we decide: invest in a single supplier, focus on a time-limited transfer of rights and verification, or split across both routes?

Who decidesEmergency General Assembly of the Joint Procurement Alliance

What the AI judgments chose

Reading the judgment record…

AI-generated editorial illustration for the Meridian library.

The options

The order shown is not a ranking of preference.

  1. Option 1

    Guarantee a single operator's reserved volume and its capacity expansion

    Secures a confirmed supply route but accepts a monopoly and a shortfall in allocation among member states.

  2. Option 2

    Concentrate budget on temporary rights transfer and joint verification

    Opens the possibility of diversified supply but takes on verification failure and lost early delivery dates.

  3. Option 3

    Secure a minimum reservation and assign the rest to phased transfer

    Keeps both routes but gives up some volume discount and speed of expansion.

The situation as it stands

In 7 days the production slots will be assigned to another buyer, and the same terms cannot be renegotiated.

Fictional international health procurement union

  1. Premise 1The supply contract for an authorized therapeutic for the fictional epidemic covers only 30% of the union's requested volume.
  2. Premise 2The rights-holding operator demands an exclusive purchase commitment in exchange for additional investment.
  3. Premise 3Four regional producers have proposed taking part in production, but verification that they guarantee the same quality is not yet complete.

Where it holdsApprove purchase guarantees for member states and temporary technology transfer contracts. It does not decide drug authorization or patient treatment for individual countries.

What can be lost

  • Lives lost and irrecoverable treatment opportunities during a supply gap
  • Harm left in future health response by supply that skipped verification or by a locked-in monopoly

What is still unknown

  1. Unknown 1When the regional producers will complete quality verification and authorization
  2. Unknown 2The scale at which a single operator's expansion actually creates additional supply

Signals to decide again

  • Independent quality verification or authorization review changes the range of what can be delivered.
  • The gap between contracted production capacity and actual shipments is confirmed in consecutive reports.
Where the paths partNot answers — paths that part from the same starting point
Independent branch 1 · synthetic event

Independent quality verification of one regional producer fails, and the delivery schedule is postponed.

Independent branch 2 · synthetic event

The power grid connection for the expansion site proposed by the rights-holding operator is delayed into the second quarter.

Material and rootsThe frame, the values and the background documents
symbolic and interpretive frame · Asclepius

How does the expansion of healing change the community's promises about distribution?

An exploratory perspective chosen by the creator. Does not claim supernatural validity or the superiority of any particular option.
Values and norms

The benefits and costs of the options accrue to different stakeholders. Which loss to accept remains undecided.

A subject for the decision-maker to argue over; the materials carry no conclusion of their own.
synthetic premise · Dilemma imported from Notion original

Original quote: A human-based response system collapses all at once Reprocessing: The premise of weakened state functions during a pandemic was expanded into an international decision in which the rights, verification, and supply contracts for a therapeutic collide, rather than automatic control.

The root of the problem-finding. The original's future events and formulations are not treated as verified facts.
The record of this question
Question
FSP-HEALTH-11 · version 1.2.0
Content identity, SHA-256
8f194dc97b5c21c36be1272061670156316038fc4ed4b9aa0f2bba1d0bd8837c
Input files
Question input JSON · What followed, JSON
See it in the record list
RISCON Labsrisconlabs.com